UCSF and GE Healthcare launch Care Innovation Hub

You May Be Interested In:First-Time TIAs Linked With Long-Term Cognitive Decline



GE HealthCare Technologies Inc. and the University of California San Francisco and its Department of Radiology and Biomedical Imaging have formed a new partnership to collaborate on advanced imaging and precision oncology, the company said.

WHY IT MATTERS 

Building on their history of working together, GE HealthCare announced that the new Care Innovation Hub brings all its collaborative research at UCSF under one framework. 

The company said the new hub will focus on improving hospital operations and increasing access to care by testing and evaluating the use of novel technologies for diagnosing and treating disease in clinical settings. 

UCSF clinical experts in brain health, neurodegenerative disease and oncology will partner with GE research and product developers to build imaging services line and precision oncology technologies at university facilities.

One of the goals is to further automation, the company said. Such endeavors include improving patient-specific magnetic resonance imaging by leveraging advanced quantitative imaging and remote scanning techniques that could adapt to patient needs in real time, and then monitoring patient response to radiopharmaceutical therapies.

To expand understanding of brain function, the collaborator will explore the links between white matter injury, vascular disease and Alzheimer’s disease to predict the treatment efficacy for brain health interventions.

“Our collaboration with GE HealthCare brings a practical focus on addressing well-defined clinical objectives,” said Sharmila Majumdar, research vice chair in UCSF’s Department of Radiology and Biomedical Imaging. “Together, we’re accelerating innovation in ways that will improve access to care and outcomes across healthcare settings.”

THE LARGER TREND

In previous years, GE and UCSF partnered on technologies to improve radiology efficiencies, such as the Critical Care Suite powered by GE’s healthcare AI X-ray platform to help providers prioritize cases involving collapsed lungs.

Artificial intelligence is transforming imaging with the number of U.S. Food and Drug Administration-approved AI tools for imaging numbering more than 300 in just the past few years with health systems partnering with vendors.

ON THE RECORD

“We’re honored to collaborate with UCSF on this important work, which has the potential to significantly improve patient outcomes and address life-threatening diseases like Alzheimer’s disease and prostate cancer worldwide,” Erin Angel, GE HealthCare’s global vice president of research and scientific affairs, said in a statement. “By combining our strengths, we’re taking steps toward solutions that meet real clinical needs.”

Andrea Fox is senior editor of Healthcare IT News.
Email: [email protected]

Healthcare IT News is a HIMSS Media publication.

share Paylaş facebook pinterest whatsapp x print

Similar Content

A health insurance claim form on a clipboard. A black pen rests on top.
Covered California Hits Record Enrollment, but Key Subsidies in Jeopardy – KFF Health News
A photo of a hand holding a well plate over out of focus sequencing results.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
Opinion | The Lifesaving Legacy of Vaccines
Opinion | The Lifesaving Legacy of Vaccines
FDA Approves Topical Tapinarof for Atopic Dermatitis
FDA Approves Topical Tapinarof for Atopic Dermatitis
Allergy medications: Know your options
Turkey or chicken stove-top casserole over toast
Lourdes Avila Uribe
16 Derm-Recommended Products To Use ASAP If You’ve Been Neglecting Your Skin
The News Link | © 2025 | News